Maravai LifeSciences Holdings, Inc. MRVI Impairment of goodwill and long-lived assets
Impairment of goodwill and long-lived assets at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept mrvi:GoodwillAndLongLivedAssetImpairment.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s impairment of goodwill and long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s impairment of goodwill and long-lived assets?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported impairment of goodwill and long-lived assets of $17.18M in Q4 2025.
- How has Maravai LifeSciences Holdings, Inc.'s impairment of goodwill and long-lived assets changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s impairment of goodwill and long-lived assets decreased by 58.6% year-over-year, from $41.54M to $17.18M.
- What does impairment of goodwill and long-lived assets mean?
- This metric captures non-cash charges recognized when the carrying value of goodwill or long-lived assets exceeds their estimated fair value. It signals a downward revision in the long-term economic outlook for specific business units or acquired assets. Investors use this to assess the historical success of capital allocation and the potential for future asset write-downs.